pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
APN-401
Head And Neck Squamous Cell Carcinoma (HNSC)
InvIOs GmbH
0
catalysts
Phase 1
APNmAb-005
Alzheimer's Disease
Aprinoia Therapeutics Inc
0
catalysts
Preclinical
APP-13002
Bacterial Conjunctivitis
Formosa Pharmaceuticals Inc
0
catalysts
Phase 2
APPA-02
Resistant Pseudomonas aeruginosa Infections
← prev
page 55 of 231
next →
131
Pain
89
Neurology
1
$ARMP
Armata Pharmaceuticals, Inc.
0
catalysts
Phase 1
APR-1051
Breast Cancer
$APRE
Aprea Therapeutics, Inc.
0
catalysts
Phase 2
APS-03118
Medullary Thyroid Cancer
Applied Pharmaceutical Science Inc
0
catalysts
Phase 2
APSA-02
Bacteremia
$ARMP
Armata Pharmaceuticals, Inc.
0
catalysts
Preclinical
APT-002
Glioblastoma Multiforme (GBM)
Aptah Bio Inc
0
catalysts
Preclinical
APT-101
Idiopathic Pulmonary Fibrosis
APIE Therapeutics Inc
0
catalysts
Preclinical
APT-110
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
AptamiR Therapeutics Inc
0
catalysts
Phase 2
APTA-16
Myelodysplastic Syndrome (Preleukemia)
AptaBio Therapeutics Inc
0
catalysts
Preclinical
AQ-002
Asthma
Aquilon Pharmaceuticals SA
0
catalysts
Preclinical
AQ-003
Chronic Obstructive Pulmonary Disease (COPD)
Aquilon Pharmaceuticals SA
0
catalysts
Preclinical
AQ-004
Lung Cancer
Aquilon Pharmaceuticals SA
0
catalysts
Phase 1
AQ-280
Eosinophilic Esophagitis
Aqilion AB
0
catalysts
Preclinical
AR-170
Solid Tumor
Y-Biologics Inc
0
catalysts
Preclinical
ARB-1002
Pancreatic Cancer
Arbele Ltd
0
catalysts
Preclinical
ARBM-201
Acute Respiratory Distress Syndrome
Arbormed Co Ltd
0
catalysts
Phase 2
ARCT-032
Cystic Fibrosis
$ARCT
Arcturus Therapeutics Holdings Inc.
0
catalysts
Phase 2
ARCT-165
Coronavirus Disease 2019 (COVID-19)
Seqirus Ltd
0
catalysts
Phase 1
ARCT-2304
Influenza A Virus, H5N1 Subtype Infections
$ARCT
Arcturus Therapeutics Holdings Inc.
0
catalysts
Phase 2
ARCT-810
Ornithine-Transcarbamylase Deficiency
$ARCT
Arcturus Therapeutics Holdings Inc.
0
catalysts
Phase 2
ARD-103
Refractory Acute Myeloid Leukemia
ARCE Therapeutics Inc
0
catalysts
ARFORMOTEROL TARTRATE INHALATION
ARFORMOTEROL TARTRATE INHALATION (ARFORMOTEROL TARTRATE INHALATION)
SLATE RUN PHARMA
0
catalysts
Preclinical
ARG-006
Hypoxic-Ischemic Encephalopathy
Argenica Therapeutics Ltd
0
catalysts
Preclinical
ARM-201
Facioscapulohumeral Muscular Dystrophy (FSHD)
Armatus Bio LLC
0
catalysts
Preclinical
ARR-002
Endometrial Cancer
Aarvik Therapeutics Inc
0
catalysts
Phase 1
ART-101
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Archeus Technologies Inc
0
catalysts
Phase 1
ART-26.12
Chemotherapy Induced Peripheral Neuropathy
$ARTL
ARTELO BIOSCIENCES, INC.
0
catalysts
Preclinical
ART-4
Alagille Syndrome
Arnatar Therapeutics Inc
0
catalysts
